Australia takes Cambridge surgical robotics technology from CMR
CMR Surgical, the UK company pioneering a revolutionary robotic arm for micro-surgery, has struck a strategically significant deal with an Australian partner.
LifeHealthcare and CMR are collaborating to bring the Cambridge company’s nextgen surgical Robotic System, Versius+ to Australia and New Zealand. The partnership is set to further expand an already advanced surgical robotics market in Australia that is experiencing a 20 per cent average annual growth in robotic procedures.
Robotically assisted procedures are most commonly adopted in urology with approximately 10,000 procedures taking place robotically each year. However, forecasts predict strong expansion across gynaecology and general surgery if existing barriers to robotics are addressed – including cost-effectiveness.
Martin Frost, chief executive at CMR Surgical, said: “Australia is a globally recognised centre for surgical innovation and a mature market for surgical robotics – making it a great fit for introducing Versius.
“By bringing a flexible, cost-effective robotic system to Australia we aim to expand the rates of minimal access surgery. To bring Versius to Australia, LifeHealthcare is a natural partner for us, with their strong record of introducing medical devices responsibly.”
Matt Muscio, CEO at LifeHealthcare addeed: “We are proud to have a healthcare sector that globally leads the way in the adoption of new technology.
“There is strong surgical robotics expertise in Australia and significant potential to help more patients experience the benefits of minimal access surgery. With CMR’s technology and our knowledge of the market we believe the introduction of Versius will be a real step change to the adoption of surgical robotics in Australia.”
The Versius Surgical Robotic System was awarded the European CE Mark in March and will launch in Europe shortly with an introduction into the Australian market to follow.